Drug Controller General (India) VG Somani in a letter dated July 17
has asked for a clarification on the matter for taking necessary
action.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dcgi-pulls-up-glenmark-for-false-claims-overpricing-of-coronavirus-drug-fabiflu/articleshow/77051308.cms
No comments:
Post a Comment